WHO releases step by step guide to help countries develop their national genomic surveillance strategy for pathogens with pandemic and epidemic potential
Ending the COVID-19 emergency and transitioning from emergency phase to longer-term disease management: guidance on calibrating the response, 4 September 2023
Know What to do During a Natural Disaster | PSAs for Disasters | CDC
Prepare for a Tsunami | PSAs for Disasters | CDC
Clean Up Safely After a Natural Disaster | PSAs for Disasters | CDC
Zika virus disease
Treating malaria
Recommended package of interventions for HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for people in prisons and other closed settings
Strengthening rehabilitation in health emergency preparedness, readiness, response and resilience: policy brief
Introducing rapid social listening and infodemic insights for action: WHO and UNICEF launch manual on 6 steps to build an infodemic insights report
Advancing the global agenda on prevention and control of noncommunicable diseases 2000 to 2020: looking forwards to 2030
Pilot protocol for influenza vaccine effectiveness against laboratory-confirmed influenza infections (symptomatic) using healthcare worker cohorts
2023-2024 CDC Flu Vaccination Recommendations Adopted
Tuberculosis (TB): migrant health guide
Public health operational guidelines for typhoid and paratyphoid (enteric fever) - version 1 - Public health operational guidelines for typhoid and paratyphoid (enteric fever) - Publications - Public Health Scotland
Pan-Canadian Action Plan on Antimicrobial Resistance - Canada.ca
The One Health approach and Key Recommendations of the Quadripartite
Tuberculosis guideline - version 1 - Tuberculosis guideline - Publications - Public Health Scotland
About HIV/AIDS | HIV Basics | HIV/AIDS | CDC
Candida auris: update to management guidance
Protective measures and options for public health response for avian influenza
Investigating Unexplained Respiratory Outbreaks (URDO) | CDC
Interim Guidance for Clinicians on Human Infections with Variant Flu
Third WHO consultation on the translation of tuberculosis research into global policy guidelines: meeting report, 4 April 2023
National tuberculosis prevalence surveys: what diagnostic algorithms should be used in future?
Global strategic preparedness, readiness and response plan for cholera
WHO announces the development of the Consolidated Guidelines on STI prevention and care (2022-2023)
Guidance on operational microplanning for COVID-19 vaccination, revised 2 May 2023
WHO consolidated guidelines on tuberculosis: Module 1: Prevention - infection prevention and control
Guidance on regulations for the transport of infectious substances 2021-2022
Quadripartite One Health Intelligence Scoping Study
Public health considerations for mpox in EU/EEA countries
Vector control products targeting outdoor malaria transmission: preferred product characteristics
Interim Guidance on Risk Assessment and Management of Persons with Potential Ebolavirus or Marburgvirus Exposure | Quarantine | CDC
Drugs to prevent COVID-19: living guideline
WHO Tools for strengthening emergency care systems
Environmental cleaning and infection prevention and control in health care facilities in low- and middle-income countries
Global climate change:
Recommendations announced for influenza vaccine composition for the 2023-2024 northern hemisphere influenza season
Guidelines for the clinical management of severe illness from influenza virus infections
WHO Ukraine crisis response: January 2023 bulletin
Methodological principles of nationally representative surveys as a platform for global surveillance of antimicrobial resistance in human bloodstream infections
Protocol for point prevalence surveys of healthcare-associated infections and antimicrobial use in European long-term care facilities – version 4.0
Adaptation and implementation of WHO's multisectoral accountability framework to end TB (MAF-TB): best practices
Global clinical data platform: Cholera case report form (CRF): module 3
Public health management of possible cases - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Operational manual on leishmaniasis vector control, surveillance, monitoring and evaluation
Introduction - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Contacts of confirmed cases of COVID-19 - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Management of COVID-19 outbreaks - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Checklist for COVID-19 outbreaks - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Vaccination - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Guidance for Cleaning, Disinfection, and Waste Disposal in Commercial Passenger Aircraft | Cleaning and Decontamination | Public Health Planners | Ebola (Ebola Virus Disease) | CDC
COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Guide for clinicians evaluating an ill person for Ebola disease | Evaluating Patients | Clinicians | Ebola (Ebola Virus Disease) | CDC
Rapid recommendation: A living WHO guideline on drugs for covid-19
Threat Assessment Brief: Implications for the EU/EEA of the spread of the SARS-CoV-2 Omicron XBB.1.5 sub-lineage
Pilot study outline for targeted genomic surveillance of SARS-CoV-2 in travellers in response to a worsening or unknown epidemiological situation in a third country
Infection prevention and controlin the context of coronavirus disease (COVID-19): A living guideline
Clinical management of COVID-19: Living guideline, 13 January 2023
Therapeutics and COVID-19: Living guideline, 13 January 2023
Infection Prevention and Control Recommendations for Hospitalized Patients Under Investigation (PUIs) for Ebola Virus Disease (EVD) in U.S. Hospitals | Ebola Virus Disease | Clinicians | Ebola (Ebola Virus Disease) | CDC
Ebola Recommendations for Organizations | Quarantine | CDC
Mpox prevention and control among people living in prison
Guidelines in response to the worsening of the epidemiological situation - Addendum to the Aviation Health Safety Protocol
Mpox prevention and control in people visiting prison
Mpox Strategic Preparedness, Readiness, and Response Plan: Global Monitoring and Evaluation Framework
COVID-19: UKHSA laboratory assessments of inactivation methods
Surveillance, case investigation and contact tracing for Monkeypox: Interim guidance
Product Information Leaflet (PIL) for VidPrevtyn Beta dispersion for injection
COVID-19 surveillance and study protocols
Antiviral resistance monitoring capability and capacity for SARS-CoV-2 and influenza within the EU/EEA
The COVID-19 risk communication package for community members in various settings
Infectious diseases in asylum seekers: actions for health professionals
ECDC expert consultation on the implementation and evaluation of non-pharmaceutical interventions
Evaluation of medicines to prevent COVID-19
Influenza Virus Genome Sequencing and Genetic Characterization | CDC
Referral of influenza samples to RVU, UKHSA Colindale, 2022 to 2023
Technical report on the COVID-19 pandemic in the UK
Interim Guidance for Influenza Outbreak Management in Long-Term Care and Post-Acute Care Facilities | CDC
CDC - Malaria - Guidance for Malaria Diagnosis in Patients Suspected of Ebola Infection in the United States
Testing & Management Flu and SARS-COV-2 in Nursing Homes
Monkeypox vaccines technical documents
COVID-19 NMA Summary Report
Investigation of SARS-CoV-2 variants: technical briefings
Health in the green economy : health co-benefits of climate change mitigation - transport sector
Background document for the SAGE October 2022 session on monkeypox vaccines
Vaccines and immunization for monkeypox: Interim guidance, 16 November 2022
Middle East respiratory syndrome: global summary and assessment of risk - 16 November 2022
Diphtheria: public health control and management in England
WHO guiding principles for pathogen genome data sharing
Cleaning and Disinfecting Your Facility
Preventing and managing outbreaks of acute respiratory illness (ARI) in the Children and Young People Secure Estate (CYPSE)
Flu and acute respiratory illness (ARI) in prisons and other prescribed places of detention (PPDs)
Bird flu: rules in disease control and prevention zones in England
Bird flu: rules if you keep game birds
Guidance for Maritime Vessels on the Mitigation and Management of COVID-19 | Quarantine | CDC
Monkeypox (MPX) | Public Health Ontario
COVID-19 outreach programmes to migrant workers: evaluating VCSOs role
Monkeypox in the U.S.
About SAGE and COVID-19 - GOV.UK
Guidance for Screening and Caring for People who are Pregnant with Ebola Virus Disease for Healthcare Providers in U.S. Hospitals | Ebola Virus Disease | Clinicians | Ebola (Ebola Virus Disease) | CDC
Laboratory support for SARS-CoV-2 virus neutralisation in the EU/EEA - a pilot study
Standard operating procedures: responding to a poliovirus event or outbreak, version 4
Guidance for Screening and Caring for Pregnant Women with Ebola Virus Disease for Healthcare Providers in U.S. Hospitals | Ebola Hemorrhagic Fever | CDC
Guidance on Air Medical Transport (AMT) for Patients with Ebola Virus Disease (EVD) | Ebola Hemorrhagic Fever | CDC
Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing
Management and safe disposal of COVID-19 vaccination waste at health facility level
COVID-19 vaccination: a guide on pregnancy and breastfeeding - GOV.UK
Action plan: National workforce capacity to implement the essential public health functions including a focus on emergency preparedness and response
One health joint plan of action (2022‒2026): working together for the health of humans, animals, plants and the environment
Viral Haemorrhagic Fever including Ebola Virus Disease | Public Health Ontario
External Evaluation of the Access To COVID-19 Tools Accelerator (ACT-A)
Guidance for School Administrators to Help Reduce the Spread of Seasonal Influenza in K-12 Schools | CDC
Guidance on Air Medical Transport (AMT) for Patients with Ebola Virus Disease (EVD) | Emergency Services | Clinicians | Ebola (Ebola Virus Disease) | CDC
COVID-19 PPE guide for adult social care services and settings - GOV.UK
Decision on Evusheld as a COVID-19 treatment - GOV.UK
Interim Clinical Considerations for Management of Ocular Monkeypox Virus Infection | Monkeypox | Poxvirus | CDC
CDC - Malaria - Diagnosis & Treatment (United States) - Treatment (U.S.) - Guidelines for Clinicians
ASPHER - ASPHER Programme for Public Health Competencies
Managing outbreaks and incidents - GOV.UK
Testing and detection of zoonotic influenza virus infections in humans in the EU/EEA, and occupational safety and health measures for those exposed at work
COVID-19 Strategic Preparedness and Response Plan 2022: Global Monitoring and Evaluation Framework
Therapeutics and COVID-19: Living guideline, 16 September 2022
WHO consolidated guidelines on tuberculosis: module 3: diagnosis: tests for TB infection
COVID-19 - information and guidance for social, community and residential care settings - version 2.4 - COVID-19 - information and guidance for social, community and residential care settings (including care homes for older people registered with the Care Inspectorate) - Publications - Public Health Scotland
Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
The EU experience in the first phase of COVID-19: implications for measuring preparedness
Guidance for General Population Disaster Shelters During the COVID-19 Pandemic | CDC
Maintaining a safe and adequate blood supply and collecting convalescent plasma in the context of the COVID-19 pandemic
Pandemic influenza risk management: a WHO guide to inform and harmonize national and international pandemic preparedness and response
4. A(H3N2) - Cell culture-derived - Southern Hemisphere 2023
COVID-19 health protection guidance - COVID-19 - Conditions and diseases - Our areas of work - Public Health Scotland
Surveillance and information sharing operational tool: an operational tool of the tripartite zoonoses guide
National protocol for Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine - GOV.UK
COVID-19 Test to Treat Guidelines for African Union Member States – Africa CDC
Autopsy and Handling of Human Remains of Patients with Monkeypox | Monkeypox | Poxvirus | CDC
Global vaccine safety blueprint 2.0 (GVSB2.0) 2021-2023
Pilot protocol for a COVID-19 vaccine effectiveness study using health data registries
Capturing the evidence on access to essential antibiotics in refugee and migrant populations
COVID-19 - information and guidance for social, community and residential care settings - version 2.3 - COVID-19 - information and guidance for social, community and residential care settings - Publications - Public Health Scotland
Clinical Considerations for Pain Management of Monkeypox | Monkeypox | Poxvirus | CDC
Clinical management of COVID-19: Living guideline, 15 September 2022
Malaria vaccines: preferred product characteristics and clinical development considerations
A guide to the COVID-19 autumn booster - GOV.UK
COVID-19: recommendations on use of adapted vaccines
Agenda for the Ministerial Lunch on Resetting the course towards ending tuberculosis and AIDS, and eliminating the epidemics of viral hepatitis and sexually transmitted infections in the WHO European Region
Human resources for medical devices, the role of biomedical engineers
Antiviral Drugs for Seasonal Influenza: Additional Links and Resources | CDC
Dietary and inhalation exposure to nano- and microplastic particles and potential implications for human health
Long-term qualitative scenarios and considerations of their implications for preparedness and response to the COVID-19 pandemic in the EU/EEA
The COVID-19 Risk Communication Package For Healthcare Facilities
Summary: ‘Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2022-23’
WHO Target Product Profiles for Monkeypox Therapeutics
Promising practices and lessons learnt in the South-East Asia Region in accessing medical oxygen during the COVID-19 pandemic
Inadvertent vaccination in pregnancy (VIP) - GOV.UK
Annexes to the interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
Eighth external quality assessment scheme for Listeria monocytogenes typing
Generic protocol for COVID-19 vaccine effectiveness studies at long-term care facilities in the EU/EEA
Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
Background document on the Valneva VLA2001 vaccine against COVID-19
Vaccines and immunization for monkeypox: Interim guidance, 24 August 2022
Monkeypox: UKHSA laboratory assessments of inactivation methods - GOV.UK
Risk communication and community engagement (RCCE) resources
Investigation and management of outbreaks of suspected acute viral respiratory infection in schools: guidance for health protection teams - GOV.UK
Investigation into monkeypox outbreak in England: technical briefing 6 - GOV.UK
Polio Investigation Information for Health Departments | CDC
Therapeutics for Ebola virus disease
Immunization in Canada: Canadian Immunization Guide - Canada.ca
WHO Guidelines for malaria
Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19
Transition of COVID-19 Hospital Reporting | NHSN | CDC
Public health taxonomy for social listening on monkeypox conversations
COVID-19: the green book, chapter 14a - GOV.UK
Lab Advisory: FDA Advises Repeat Testing to Reduce False Negative Results with COVID-19 Antigen Tests
MGN 652 (M+F) Amendment 1 infectious disease at sea - GOV.UK
Polio Vaccination Recommendations for Specific Groups | CDC
CDC streamlines COVID-19 guidance to help the public better protect themselves and understand their risk | CDC Online Newsroom | CDC
Inactivated polio vaccine (IPV) booster: information for healthcare practitioners - GOV.UK
Vaccination Administration Considerations for Specific Populations | Monkeypox | Poxvirus | CDC
Vaccination Strategies | Monkeypox | Poxvirus | CDC
JYNNEOS Vaccine | Monkeypox | Poxvirus | CDC
ACAM2000 Vaccine | Monkeypox | Poxvirus | CDC
The regulatory and certification framework for institutions handling high risk pathogens in the Africa Region – Africa CDC
Clinical Recognition | Monkeypox | Poxvirus | CDC
Investigation into monkeypox outbreak in England: technical briefing 5 - GOV.UK
Janssen Jcovden® (Johnson & Johnson) COVID-19 vaccine - Canada.ca
Management of critical COVID-19: Acute hypoxaemic respiratory failure and COVID-19
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Novavax COVID-19 Vaccine
Preparation and administration of mAb114 for Ebola virus disease (EVD)
WHO Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals
Methods for the detection and characterisation of SARS-CoV-2 variants - second update
Summary of Product Characteristics for Vaxzevria - GOV.UK
Monkeypox: diagnostic testing - GOV.UK
COVID-19: guidance for health professionals - GOV.UK
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations
Monitoring HIV pre-exposure prophylaxis programmes in the EU/EEA
Clinical Considerations for Monkeypox in Children and Adolescents | Monkeypox | Poxvirus | CDC
WHO's Response to the Ukraine Crisis
Guidelines on long-acting injectable cabotegravir for HIV prevention
GRADE: Moderna COVID-19 Vaccine for Persons Aged 12-17 Years | CDC
GRADE: Moderna COVID-19 Vaccine for Children Aged 6-11 Years | CDC
ACIP Evidence to Recommendations for Use of Moderna COVID-19 Vaccine in Children Ages 6 – 17 Years under an Emergency Use Authorization | CDC
Malaria chemoprevention efficacy study protocol
Differentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance
COMEAP advice note: Environment Act PM2.5 targets - GOV.UK
Investigation into monkeypox outbreak in England: technical briefing 4 - GOV.UK
Case Reporting Recommendations for Health Departments | Monkeypox | Poxvirus | CDC
Disinfecting Home and Other Non-Healthcare Settings | Monkeypox | Poxvirus | CDC
Investigation into monkeypox outbreak in England: technical briefing 3 - GOV.UK
Joint WHO Regional Office for Europe/ECDC Monkeypox Resource toolkit to support national authorities and event organisers in their planning and coordination of mass and large gathering events
Monkeypox multi-country outbreak - first update
Monkeypox outbreak: Resource toolkit for event organisers
Monkeypox: planning events and mass gatherings - GOV.UK
How to Report Test Results | Monkeypox | Poxvirus | CDC
Considerations for contact tracing during the monkeypox outbreak in Europe, 2022
Preparation and Collection of Specimens | Monkeypox | Poxvirus | CDC
Laboratory Procedures | Monkeypox | Poxvirus | CDC
Risk communication and community engagement (RCCE) for monkeypox outbreaks: Interim guidance, 24 June 2022
Lab Advisory: CDC Updates Specimen Collection Guidelines for Monkeypox Virus
Treatment Information for Healthcare Professionals | Monkeypox | Poxvirus | CDC
Lab Advisory: CDC Publishes Monkeypox Virus PCR Testing Procedure
Vaccines and immunization for monkeypox: Interim guidance, 14 June 2022
Monkeypox Virus | Public Health Ontario
Monkeypox: secure and detained settings - GOV.UK
Principles for monkeypox control in the UK: 4 nations consensus statement - GOV.UK
De-isolation and discharge of monkeypox-infected patients: interim guidance - GOV.UK
Monitoring People Who Have Been Exposed | Monkeypox | Poxvirus | CDC
Monkeypox: case definitions - GOV.UK
Laboratory testing for the monkeypox virus: Interim guidance
Risk assessment: Monkeypox multi-country outbreak
Interim Clinical Guidance for the Treatment of Monkeypox | Monkeypox | Poxvirus | CDC
Infection Control: Healthcare Settings | Monkeypox | Poxvirus | CDC
Case Definition† | Monkeypox | Poxvirus | CDC
Lab Advisory: CDC Specimen Collection Guidelines for Monkeypox Virus
Management of suspected monkeypox in primary and community care - version 1 - Management of suspected monkeypox in primary and community care - Publications - Public Health Scotland
Monkeypox vaccination - GOV.UK
Personal Protective Equipment (PPE) portal - GOV.UK
Using the WHO online COVID-19 public health and social measures calibration tool: a step-by-step guide
Performance measurement evaluation for risk management of dioxins and furans (health component) - Canada.ca
WHO Drug Information - Volume 36, No. 2
Identifying and responding to serious adverse events following immunization, following use of smallpox vaccine during a public health emergency: a guidance document for smallpox vaccine safety surveillance
Appendix A: groups included in the national influenza immunisation programme - GOV.UK
WHO preferred product characteristics for monoclonal antibodies for HIV prevention
Public health surveillance for COVID-19: interim guidance
COVID-19 guidance for prison settings - version 2.1 - COVID-19 guidance for prison settings - Publications - Public Health Scotland
Schistosoma – Serology | Public Health Ontario
COVID-19 testing in homelessness, domestic abuse refuge and respite room settings - GOV.UK
Global COVID-19 Vaccination Strategy in a Changing World: July 2022 update
Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States
Guidance for Cruise Ships on the Mitigation and Management of COVID-19 | Quarantine | CDC
Influenza of avian origin in UK seal populations: qualitative assessment of the risk to the UK human population - GOV.UK
Reporting Death or Illness on Ships | Quarantine | CDC
Preliminary public health considerations for COVID-19 vaccination strategies in the second half of 2022
Operational considerations for respiratory virus surveillance in Europe
Antimicrobial Resistance in the EU/EEA - A One Health response
Therapeutics and COVID-19: living guideline
Interim recommendations on COVID-19 vaccination in autumn 2022 for the WHO European Region: conclusions and recommendations of the European Technical Advisory Group of Experts on Immunization
Bacterial vaccines in clinical and preclinical development 2021
COVID-19 - guidance for health protection teams (HPTs) - version 2.4 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
COVID-19 Contact tracing: country experiences and way forward
WHO consolidated guidelines on tuberculosis: module 4: treatment: tuberculosis care and support
Interim guidance on the use of rapid antigen detection tests for the identification of SARS-CoV-2 infection - Canada.ca
Contact tracing and quarantine in the context of COVID-19: interim guidance, 6 July 2022
Joint external evaluation tool: International Health Regulations (2005) - third edition
Clinical management of COVID-19: Living guideline, 23 June 2022
Health emergency preparedness for imported cases of high-consequence infectious diseases
COVID-19 information and guidance for workplaces and community settings- version 1.2 - COVID-19 information and guidance for workplaces and community settings - Publications - Public Health Scotland
Manual for monitoring insecticide resistance in mosquito vectors and selecting appropriate interventions
Indoor residual surface treatments for malaria transmission control in areas with insecticide-resistant mosquito populations
COVID-19 - guidance for health protection teams (HPTs) - version 2.3 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Digital solutions to health risks raised by the COVID-19 infodemic. Synthesis Report
CDC Requirements for Immigrant Medical Examinations: COVID-19 Technical Instructions for Panel Physicians | Immigrant and Refugee Health | CDC
COVID-19 guidance for prison settings - version 2 - COVID-19 guidance for prison settings - Publications - Public Health Scotland
Highest-risk patients eligible for COVID-19 treatments: guide for patients - GOV.UK
Manual for investigating suspected outbreaks of illnesses of possible chemical etiology: guidance for investigation and control
WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
Technical guidance for antigenic SARS-CoV-2 monitoring
Severity of disease associated with Omicron variant as compared with Delta variant in hospitalized patients with suspected or confirmed SARS-CoV-2 infection
Infection Prevention and Control Assessment Tool for Nursing Homes Preparing for COVID-19 | HAI | CDC
COVID-19 in Newly Resettled Refugee Populations | Immigrant and Refugee Health | CDC
Sinopharm [Vero Cell]- Inactivated, COVID-19 vaccine
Guidance for diagnostic testing of cases with severe acute hepatitis of unknown aetiology in children
Joint Committee on Vaccination and Immunisation (JCVI) interim statement on the COVID-19 vaccination programme for autumn 2022 - GOV.UK
Interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19
Interim Guidance for Ships on Managing Suspected or Confirmed Cases of Coronavirus Disease 2019 (COVID-19) | Quarantine | CDC
WHO guidelines on tuberculosis infection prevention and control: 2019 update
Coronavirus Disease 2019 (COVID-19) - Variant of Concern Screening and Whole Genome Sequencing Surveillance | Public Health Ontario
Table 3: WHO recommendations for routine immunization
COVID-19 Aviation Health Safety Protocol: Operational guidelines for the management of air passengers and aviation personnel in relation to the COVID-19 pandemic
Manual for selection of molecular WHO recommended rapid diagnostic tests for detection of tuberculosis and drug-resistant tuberculosis
Practical manual of processing stool samples for diagnosis of childhood TB
Monitoring reports of the effectiveness of COVID-19 vaccination - GOV.UK
National protocol for Vaxzevria COVID-19 Vaccine (ChAdOx1-S [recombinant]) - GOV.UK
Vaccine update: issue 327, May 2022, SCID, TB and BCG special edition - GOV.UK
Instructions for Adenovirus Diagnostic Testing, Typing, and Submission | CDC
Clinical Guidance for Adenovirus Testing and Typing of Patients Under Investigation | CDC
Pre-exposure Prophylaxis (PrEP) | Prevention | CDC
Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 | MMWR
Methods for estimating the excess mortality associated with the COVID-19 pandemic
Coronavirus (COVID-19) testing for hospices - GOV.UK
ACIP Evidence to Recommendations for Booster Dose of Rabies Vaccine After the 2-dose Pre-exposure Prophylaxis Schedule | CDC
ACIP Evidence to Recommendations for Rabies Pre-exposure prophylaxis with a 2-dose Schedule | CDC
Rapid communication: Key changes to the treatment of drug-resistant tuberculosis
Avian influenza (bird flu) - GOV.UK
Hepatitis (Acute) – Unknown Origin in Children | Public Health Ontario
ASPHER - Updating Core Competencies In Applied Infectious Disease Epidemiology (UCCAIDE)
Hepatitis of unknown origin - Reporting protocol 2022
Increase in severe acute hepatitis cases of unknown aetiology in children
Transitioning beyond the acute phase of the COVID-19 pandemic: Approaches and tools used by a sample of EU countries in the transition and de-escalation phase – interim report
Assessment of point-of-care testing devices for infectious disease surveillance, prevention and control – a mapping exercise
Sinovac CoronaVac® [Vero Cell]- Inactivated, COVID-19 vaccine
COVID-19 information and guidance for workplaces and community settings - version 1.0 - COVID-19 information and guidance for workplaces and community settings - Publications - Public Health Scotland
Summary of Product Characteristics Comirnaty 30 micrograms/dose concentrate (purple cap) - GOV.UK
Eliminate Yellow Fever Epidemics (EYE) 2017 – 2026
COVID-19 treatments - Canada.ca
Societal Experts Action Network: Strategies for Communicating with People Who Are Not Vaccinated to Build Confidence in Covid-19 Vaccines | The National Academies Press
Patient Information Leaflet for Comirnaty 10 micrograms/dose concentrate (orange cap) - GOV.UK
Environmental surveillance for SARS-COV-2 to complement public health surveillance – Interim Guidance
COVID-19 Emergency ICD Codes
How to temperature map cold chain equipment and storage areas
Strategic and Technical Advisory Group on Infectious Hazards with Pandemic and Epidemic Potential (STAG-IH) Terms of reference
High consequence infectious diseases (HCID) - GOV.UK
WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Susceptible Tuberculosis Treatment
Clinical care of severe acute respiratory infections – Tool kit
Core competencies in applied disease epidemiology in Europe: facilitating collaboration and the use of a common language among professionals
COVID-19 - information and guidance for care home settings (for older adults) - COVID-19 - information and guidance for care home settings (for older adults) - Publications - Public Health Scotland
Testing for tuberculosis infection and screening for tuberculosis disease among refugees arriving in European countries from Ukraine
Guidance for Collection, Transport and Submission of Specimens for Ebola Virus Testing | For Laboratory Personnel | Ebola (Ebola Virus Disease) | CDC
COVID-19: guidance for people whose immune system means they are at higher risk - GOV.UK
Waterbone outbreaks of hepatitis E: recognition, investigation and control: technical report
Operational Guide: The early warning and response systems (EWARS) for Dengue Outbreaks
Cansino Ad5-nCoV-S vaccine recommendations for use
Communicating risk in public health emergencies
Hepatitis B - Vaccination of Adults | CDC
Coronavirus Disease 2019 (COVID-19) – Serology | Public Health Ontario
No more neglect — Female genital schistosomiasis and HIV — Integrating sexual and reproductive health interventions to improve women's lives
Surveillance for human infection with Middle East respiratory syndrome coronavirus (MERS - CoV)
The humanitarian emergency settings perceived needs scale (HESPER)
Interim guideline: nutritional care of children and adults with Ebola virus disease in treatment centres: key recommendations
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
Diagnostics for Detecting H7N9 Using rRT-PCR | Avian Influenza (Flu)
The NHS influenza immunisation programme 2022 to 2023
Target product profile for a point-of-care diagnostic test for dermal leishmaniases
Vaccine Testing and Approval Process | CDC
COVID-19 - information and guidance for social, community and residential care settings - version 2.1 - COVID-19 - information and guidance for social, community and residential care settings - Publications - Public Health Scotland
Global genomic surveillance strategy for pathogens with pandemic and epidemic potential, 2022–2032
Anthrax Diagnostic Testing Recommendations by Specimen Type| CDC
Line probe assays for detection of drug-resistant tuberculosis: interpretation and reporting manual for laboratory staff and clinicians
Solidarity Trial Vaccines (STV) presentation
Coronavirus (COVID-19) testing for adult social care services - GOV.UK
Interim Guidance on Follow-up of Close Contacts of Persons Infected with Novel Influenza A Viruses and Use of Antiviral Medications for Chemoprophylaxis | Avian Influenza (Flu)
Burkholderia mallei and Burkholderia pseudomallei – Confirmation | Public Health Ontario
Summary of Product Characteristics for Nuvaxovid dispersion for injection - GOV.UK
Summary of Product Characteristics for Spikevax - GOV.UK
Health systems resilience toolkit: a WHO global public health good to support building and strengthening of sustainable health systems resilience in countries with various contexts
COVID-19 vaccination: guide for employers - GOV.UK
Decarcerating Correctional Facilities during COVID-19: Advancing Health, Equity, and Safety: Report Overview | The National Academies Press
Patient Information Leaflet for Spikevax - GOV.UK
Strengthening COVID-19 vaccine demand and uptake in refugees and migrants
Guiding for impact in a rapidly changing world
Reducing the spread of respiratory infections, including COVID-19, in the workplace
Molluscum contagiosum virus detection | Public Health Ontario
Maternal nutrition in emergencies
Pfizer-BioNTech COVID-19 Vaccine Overview and Safety | CDC
Interim Guidance on the Use of Antiviral Medications for Treatment of Human Infections with Novel Influenza A Viruses Associated with Severe Human Disease | Avian Influenza (Flu)
Acute hepatitis: technical briefing - GOV.UK
Global Competency and Outcomes Framework for Universal Health Coverage
How CDC Determines the Level for COVID-19 Travel Health Notices | CDC
Hospital Preparedness for Epidemics
Diagnostic testing and screening for SARS-CoV-2
Preventing and controlling outbreaks of COVID-19 in prisons and places of detention - GOV.UK
Infection prevention and control in adult social care: COVID-19 supplement
ESAC-Net Reporting Protocol 2022
Vaccination requirements and recommendations for international travellers; and malaria situation per country – 2021 edition
Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits, 2nd ed
Interim guidance on COVID-19 Rapid Antigen self-testing to African Union Member States
Good practices for selecting and procuring rapid diagnostic tests for malaria
Screening for Lead during the Domestic Medical Examination for Newly Arrived Refugees
Maintaining essential health services during the COVID-19 outbreak
Global epidemiological surveillance standards for influenza
Meeting of the Strategic Advisory Group of Experts on Immunization, October 2014: conclusions and recommendations
Recommendations announced for influenza vaccine composition for the 2022-2023 northern hemisphere influenza season
Definitions and reporting framework for tuberculosis
European External Influenza Virus Quality Assessment Programme – 2020 data
WHO treatment guidelines for drug-resistant tuberculosis, 2016 update
Use of COVID-19 Vaccines in the United States
COVID-19 - information and guidance for social, community and residential care settings
Pfizer-BioNTech COVID-19 Vaccine (Gray Cap) Age 12 and Over
Caring for those who care: guide for the development and implementation of occupational health and safety programmes for health workers: executive summary
WHO guideline on health workforce development, attraction, recruitment and retention in rural and remote areas
Health workforce development, attraction, recruitment and retention in rural and remote areas
Treatment and pharmaceutical prophylaxis of COVID-19
Adult Immunization Schedule
Adult Immunization Schedule by Medical Condition and Other Indication
Child and Adolescent Immunization Schedule by Medical Indication
Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination
JCVI statement on vaccination of children aged 5 to 11 years old
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2022
Operational public health considerations for the prevention and control of infectious diseases in the context of Russia’s aggression towards Ukraine
Instructions for Submitting Diagnostic Specimens for Testing by the Rickettsial Reference Diagnostic Laboratory
WHO released a new operational guide to promote COVID-19 vaccination uptake and tackle vaccine hesitancy among refugees and migrants
Preview Posting of COVID-19 Vaccine Codes and Crosswalk for Currently Authorized Vaccines and Anticipation of Potential Vaccine Availability under Emergency Use Authorization (EUA)
Guidelines on the public health response to pretreatment HIV drug resistance
COVID-19 testing, vaccination and implementation of protective measures recommended for reception centres of displaced people from Ukraine
Preferred Product Characteristics for Personal Protective Equipment for the Health Worker on the Frontline Responding to Viral Hemorrhagic Fevers in Tropical Climates
Preventing or limiting the spread of COVID-19 on cruise ships
Coronavirus (COVID-19) test kits for children's homes
Herpes B Virus – Serology and PCR
Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: Round 8 (2016-2018)
Guidelines for prevention and control of Chikungunya fever
Interim Guidance on Testing, Specimen Collection, and Processing for Patients with Suspected Infection with Novel Influenza A Viruses with the Potential to Cause Severe Disease in Humans
Haemophilus influenzae Disease (Including Hib)
Global technical strategy for malaria 2016–2030
Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
WHO guidelines for the prevention of sexual transmission of Zika virus
Strategic planning for implementation of the health-related articles of the Minamata Convention on Mercury
Ukraine: migrant health guide
Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults
Pfizer-BioNTech Comirnaty COVID-19 vaccine
Interim Guidance for Infection Control Within Healthcare Settings When Caring for Confirmed Cases, Probable Cases, and Cases Under Investigation for Infection with Novel Influenza A Viruses Associated with Severe Disease
Antimicrobial Stewardship Strategies
Core questions and indicators for monitoring WASH in health care facilities in the Sustainable Development Goals
WHO technical brief for countries preparing malaria funding requests for the Global Fund (2020–2022)
Guidance for the prevention and control of COVID-19 in temporary reception centres in the context of the large numbers of people fleeing Ukraine
WHO guideline on control and elimination of human schistosomiasis
Technical Instructions for CDC’s COVID-19 Program for Cruise Ships Operating in U.S. Waters
Recommendations for Worker Protection and Use of Personal Protective Equipment (PPE) to Reduce Exposure to Novel Influenza A Viruses Associated with Severe Disease in Humans
Everyone’s business: Whole-of-society action to manage health risks and reduce socio-economic impacts of emergencies and disasters: Operational guidance
WHO policy guidance on integrated antimicrobial stewardship activities
WHO guidelines on use of medically important antimicrobials in food-producing animals
Hepatitis A – Serology
COVID-19: people with COVID-19 and their contacts
